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Abstract
Infection of renal or hepatic cyst is a serious complication of autosomal dominant polycystic kidney disease (ADPKD) and 
early diagnosis is crucial for the correct management. We report a case of 64-year-old male with ADPKD, who required renal 
transplantation some years before, with recent recurrent episodes of fever and abdominal pain, who underwent 18F-FDG PET/CT 
twice at 18 months intervals, after not conclusive conventional imaging studies (CT, ultrasonography). 18F-FDG PET/CT has 
proven to be a useful method for the diagnosis of renal and hepatic cyst infection in a patient with ADPKD and for the subse-
quent management.
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Background
Autosomal dominant polycystic kidney disease (ADPKD) is one 
of the most common hereditary disorders affecting approximately 
1 in 500–1000 individuals [1]. Over 50% of patients with ADPKD 
eventually develop end stage kidney disease and require dialysis or 
kidney transplantation [2]. Usually the diagnosis is performed by re-
nal imaging using ultrasound, CT or MRI but all these methods have 
some limits especially in patients with end stage renal disease. The 
role of 18F-FDG PET/CT is still not clear.
Case report
A 64-year-old male with a history of ADPKD, left-sided ne-
phrectomy and renal transplantation from deceased donor in 1996, 
presented with a 3-weeks history of fever, chills and abdominal 
pain not responsive to antipyretics. Laboratory findings showed 
elevations of C-reactive protein levels (200 mg/dL), procalcitonin 
(12 ng/mL) and creatinine (2.9 mg/dL); liver enzymes and leuko-
cytes were normal and urine culture was negative. An abdominal 
ultrasound and abdominal CT showed the presence of multiple 
cyst in the right kidney without signs of infection. Patient started 
empirical parenteral antibiotic therapy (piperacillin-tazobactam) 
but the symptoms persisted, so he underwent a positron emis-
sion tomography with computed tomography (PET/CT) scan. 
18F-FDG PET/CT was performed after intravenous administration 
of 3.5 MBq/kg; total body images were acquired 60 minutes after 
injection on Discovery ST tomograph (GE — Milwaukee, Wi, USA; 
4-slice-CT, 80 mA, 120 Kv; 3 minutes PET-bed; 128 × 128 matrix, 
60 cm field of view). PET/CT revealed moderate uptake of FDG at 
the ring shape of the wall of one renal cyst in the upper right kidney. 
No other pathological uptakes were discovered in the remaining 
body studied (Figure 1). Cyst fluid culture was positive for Escheri-
chia coli. Then the patient underwent radical right nephrectomy, 
symptoms disappeared and laboratory findings returned normal. 
After 18 months from first PET/CT scan, patient returned for a new 
febrile episode with a blood culture positive for Escherichia coli. 
PCR was 362 mg/dL, procalcitonin 182 ng/mL. An abdominal CT 
revealed hepatic polycystosis with biggest cyst about 8 cm in 
the segment VIII. After a new fever pitch, the patient underwent 
an 18F-FDG PET/CT to search infective foci, which showed an in-
creased FDG uptake in the liver corresponding to the wall of a big 
hepatic cyst between segment VI and VII. Besides, increased 
metabolic activity was seen in some mediastinal nodes (Figure 2). 
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Antibiotic therapy with daptomycin and ceftriaxone was started 
successfully.
Discussion
ADPKD is the most frequent genetic kidney disease and cyst 
infection, both hepatic and renal, is an important challenging 
diagnostic issue in these patients because of potential danger-
ous complication [3]. The diagnosis of cyst infection is difficult 
because of the lack of specific signs and symptoms [4] and the 
limitation of conventional imaging procedures (like ultrasound, CT 
and MRI) especially in patients with renal failure [5–7]. Sallèe et 
al. [7] and Balbo et al. [8] compared sensitivities of ultrasound, 
CT, MRI and PET/CT in patient with ADPKD and suspected cyst 
infection proving the superiority of PET/CT. The actual role of 
PET/CT is still not clear. A few reports described the role of PET 
in detecting cyst infection, either renal [9–13] or hepatic [14–17] 
or both [18–21], in patients with ADPKD, particularly recognizing 
Figure 2 A–D. Axial CT (A), axial PET (B) and axial PET/CT (C) shows an increased FDG 
uptake in the liver between segment VI and VII corresponding to the wall of a big hepatic 
cyst. MIP (D) shows some mediastinal nodes FDG avid (thin arrows)
Figure 1A–D. Axial CT (A), axial PET (B) and axial PET/CT (C) displays one renal cyst with 
ring shape of the wall FDG avid in the right kidney. Maximum intensity projection, MIP, 
shows no other pathological uptakes in the remaining body studied (D)
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if there is an infective process in progress, guiding the biopsy 
and the better treatment. Our case is of interest because the 
PET/CT has proven to be useful in the early diagnosis either of 
renal cyst or hepatic cyst infection in a patient with ADPKD and 
unresponsive fever and guiding the choice of the correct manage-
ment of the patient.
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